Login to Your Account



30th Annual J.P. Morgan Healthcare Conference

Regulatory Inconsistency, Missed Handoffs Threaten Innovation

By Marie Powers
Staff Writer

Wednesday, January 11, 2012
SAN FRANCISCO – The nexus of clinical development, regulation and capital was the focus of a panel convened Tuesday at the 30th annual J.P. Morgan Healthcare Conference to discuss a biomedical industry CEO survey conducted by the nonprofit California Healthcare Initiative (CHI), the Northern California life science association BayBio and the pharmaceutical, medical device and life sciences industry group at PricewaterhouseCoopers (PwC).

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription